AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
A genomics company, a crypto foundation, and the former CEO are all looking at this treasure trove of genetic data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback